Health Care·Health Care Technology·$2.6B
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $-0.12 | N/A | +50.00% |
| Revenue | N/A | N/A | N/A |
management commentary, guidance changes, and full analysis available with Pro.
| EPS | $-0.12 | N/A | +50.00% |
| Revenue | N/A | N/A | N/A |
Tone: Cautiously Optimistic
Management expressed satisfaction with the EPS performance, highlighting cost management and innovation. They emphasized their commitment to growth despite not providing specific guidance.
We are pleased with our progress in managing costs while continuing to innovate.
Our focus remains on expanding our market presence and enhancing our product offerings.
HeartFlow's earnings report shows a positive surprise in EPS, which contributed to a 13.10% increase in stock price. The company is focusing on cost management and innovation, indicating a strategic approach to growth. However, the lack of revenue data and future guidance leaves some uncertainty for investors.
AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.
No charge today · Auto-bills $8/mo after 7 days · Cancel anytime
SCIENCE APPLICATIONS
Mar 16, 2026